HER2 (ERBB2) — Targeted Therapies, Trials & Pipeline

Receptor tyrosine kinase amplified/overexpressed or mutated across breast, gastric, colorectal, lung and other tumors; targeted by antibodies, ADCs, and TKIs.

Approved drugs targeting HER2 (ERBB2)

Investigational pipeline agents

Landmark trials